AKBA - Akebia Therapeutics Stock Trading

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today announced that its President and Chief Executive Officer, John P. Butler, will present at the 38 th Annual J.P...

Historian -- an unsuccessful novelist ." - H.L. Mencken Today, we take a deeper look at a small biotech concern that has been very volatile in its history as a public company. However, it has potential catalysts on the horizon and has picked up some insider buying of late as well. A full...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than five years. This subset of the different portfolios I regularly analyze has now reached 133 weeks of public selections as part of this ongoing live forward-testing. ...